Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01TNW
|
||||
| Former ID |
DCL000101
|
||||
| Drug Name |
Dapagliflozin
|
||||
| Synonyms |
BMS 512148; BMS-512148; BMS-512148, Dapagliflozin; Dapagliflozin (INN/USAN); 2-(3-(4-Ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Company |
AstraZeneca
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C21H25ClO6
|
||||
| InChI |
InChI=1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1
|
||||
| InChIKey |
JVHXJTBJCFBINQ-ADAARDCZSA-N
|
||||
| CAS Number |
CAS 461432-26-8
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
14855234, 15451267, 24173975, 45634651, 49688954, 57304407, 57373691, 76500746, 96025580, 103578280, 104253204, 109692963, 123051086, 124757330, 124772065, 125164134, 126667088, 126731318, 134338792, 134358357, 136348250, 136367545, 136367974, 137261282, 140046947, 143499356, 144115882, 152234916, 152258220, 160647056, 162011553, 162037657, 162172238, 164838825, 165245557, 170497930, 174529446, 175427068, 178101315, 185978787, 194946819, 198934677, 198991956, 210024059, 211535346, 221678783, 223471387, 223554897, 223670709, 223701082
|
||||
| SuperDrug ATC ID |
A10BX09
|
||||
| Target and Pathway | |||||
| Target(s) | SLGT2 | Target Info | Modulator | [533123] | |
| References | |||||
| Ref 467834 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4594). | ||||
| Ref 533123 | 2014 FDA drug approvals. Nat Rev Drug Discov. 2015 Feb;14(2):77-81. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.